Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

8.06
+0.06000.75%
Post-market: 8.150.0873+1.08%19:56 EDT
Volume:1.12M
Turnover:9.04M
Market Cap:2.53B
PE:-191.45
High:8.14
Open:8.00
Low:7.97
Close:8.00
Loading ...

Amneal Pharmaceuticals' Brekiya Approved by FDA

MT Newswires Live
·
15 May

BUZZ-Amneal rises after US FDA greenlights self-administered migraine treatment

Reuters
·
15 May

US FDA approves Amneal's migraine treatment

Reuters
·
15 May

Amneal Pharmaceuticals Inc. Receives FDA Approval for Brekiya® Autoinjector for Acute Migraine and Cluster Headache Treatment

Reuters
·
15 May

Piper Sandler Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
14 May

Director John Kiely Reports Disposal of Common Shares of Amneal Pharmaceuticals Inc

Reuters
·
14 May

Stock Track | Amneal Pharmaceuticals Soars 5.06% on Production Expansion and Manufacturing Collaboration

Stock Track
·
09 May

Stock Track | Amneal Pharmaceuticals Soars 5.06% on Major Manufacturing Expansion Plans

Stock Track
·
09 May

Truist Financial Remains a Buy on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
05 May

Amneal Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
02 May

Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Affirmed

MT Newswires Live
·
02 May

GUIDANCE: (AMRX) Amneal Pharmaceuticals Expects Full Year 2025 Net Revenue Range $3.0B - $3.1B, vs. FactSet Est of $3.03B

MT Newswires Live
·
02 May

BRIEF-Amneal Pharmaceuticals Q1 Revenue USD 695.42 Million

Reuters
·
02 May

Amneal Pharmaceuticals Inc expected to post earnings of 15 cents a share - Earnings Preview

Reuters
·
30 Apr

3 Profitable Stocks Skating on Thin Ice

StockStory
·
29 Apr

Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month

Business Wire
·
11 Apr

Amneal Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk

Dow Jones
·
10 Apr

Press Release: Amneal to Report First Quarter 2025 Results on May 2, 2025

Dow Jones
·
09 Apr

BRIEF-Amneal Announces New Data From Phase 3 Study

Reuters
·
07 Apr

Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease

Business Wire
·
07 Apr